Mosquito-borne malaria kills over 600,000 people each year, mostly children. Treatments and anti-mosquito measures such as mosquito nets have reduced the death toll, but rates rose during the COVID-19 pandemic when social disruptions stymied healthcare systems and organizations dedicated to malaria prevention.
Now, scientists say they have a more permanent solution to the problem. By inserting genes that make anti-malaria antibodies into mosquitos, the researchers have inoculated not only that generation of mosquitos, but their offspring and their offspring鈥檚 offspring against carrying and passing on the malaria parasite.
Releasing batches of these genetically modified mosquitos into the wild could reduce new human malaria infections by over 90% within three months, according to modeling published in the journal PNAS. That would represent some 216 million fewer cases a year, given that the World Health Organization (WHO) estimates that there are approximately 240 million new malaria cases annually.
Led by study leader Anthony James, a molecular geneticist at the Univ. of California, Irvine, a team of researchers developed what鈥檚 called a 鈥済ene drive鈥� system to alter mosquito genomes in a way that would spread throughout the population rapidly. Malaria spreads when a mosquito bites an infected person, and the mosquito itself becomes infected with the parasite that causes the disease...
Would you like to access the complete CEP News Update?
No problem. You just have to complete the following steps.
You have completed 0 of 2 steps.
-
Log in
You must be logged in to view this content. Log in now.
-
AIChE Membership
You must be an AIChE member to view this article. Join now.
Copyright Permissions
Would you like to reuse content from CEP Magazine? It鈥檚 easy to request permission to reuse content. Simply to connect instantly to licensing services, where you can choose from a list of options regarding how you would like to reuse the desired content and complete the transaction.